Novel psychoactive substances (NPS) are chemically engineered substances designed to mimic the effects of traditional controlled drugs such as opioids, stimulants, and cannabinoids. These compounds pose significant health risks due to their unpredictable potency and toxicity. There is little evidence to suggest NPS are manufactured within the U.K. China has long been identified as the primary source of these drugs, with its chemical manufacturing sector supplying to global markets.
This article was originally published on MedicalXpress.com
